Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD.
Balgoma D, Yang M, Sjödin M, Snowden S, Karimi R, Levänen B, Merikallio H, Kaarteenaho R, Palmberg L, Larsson K, Erle DJ, Dahlén SE, Dahlén B, Sköld CM, Wheelock ÅM, Wheelock CE. Balgoma D, et al. Among authors: dahlen b, dahlen se. Eur Respir J. 2016 Jun;47(6):1645-56. doi: 10.1183/13993003.01080-2015. Epub 2016 Mar 10. Eur Respir J. 2016. PMID: 26965288 Free article.
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE, Malmström K, Nizankowska E, Dahlén B, Kuna P, Kowalski M, Lumry WR, Picado C, Stevenson DD, Bousquet J, Pauwels R, Holgate ST, Shahane A, Zhang J, Reiss TF, Szczeklik A. Dahlén SE, et al. Among authors: dahlen b. Am J Respir Crit Care Med. 2002 Jan 1;165(1):9-14. doi: 10.1164/ajrccm.165.1.2010080. Am J Respir Crit Care Med. 2002. PMID: 11779723 Clinical Trial.
Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.
Gyllfors P, Bochenek G, Overholt J, Drupka D, Kumlin M, Sheller J, Nizankowska E, Isakson PC, Mejza F, Lefkowith JB, Dahlén SE, Szczeklik A, Murray JJ, Dahlén B. Gyllfors P, et al. Among authors: dahlen b, dahlen se. J Allergy Clin Immunol. 2003 May;111(5):1116-21. doi: 10.1067/mai.2003.1450. J Allergy Clin Immunol. 2003. PMID: 12743579 Clinical Trial.
[TNF-blockade--new strategy in difficult-to-treat asthma].
Dahlén SE, Millinger E, Skedinger M, Zetterström O, Dahlén B. Dahlén SE, et al. Among authors: dahlen b. Lakartidningen. 2008 Jun 25-Jul 1;105(26-27):1946-8. Lakartidningen. 2008. PMID: 18681378 Swedish. No abstract available.
Increased intraepithelial T-cells in stable COPD.
Löfdahl MJ, Roos-Engstrand E, Pourazar J, Bucht A, Dahlen B, Elmberger G, Blomberg A, Sköld CM. Löfdahl MJ, et al. Among authors: dahlen b. Respir Med. 2008 Dec;102(12):1812-8. doi: 10.1016/j.rmed.2008.06.013. Epub 2008 Aug 15. Respir Med. 2008. PMID: 18706796 Free article.
Toll-like receptor expression in smokers with and without COPD.
von Scheele I, Larsson K, Dahlén B, Billing B, Skedinger M, Lantz AS, Palmberg L. von Scheele I, et al. Among authors: dahlen b. Respir Med. 2011 Aug;105(8):1222-30. doi: 10.1016/j.rmed.2011.02.012. Epub 2011 Mar 24. Respir Med. 2011. PMID: 21439805 Free article.
Asthma treatment guidelines meet the real world.
Dahlén SE, Dahlén B, Drazen JM. Dahlén SE, et al. Among authors: dahlen b. N Engl J Med. 2011 May 5;364(18):1769-70. doi: 10.1056/NEJMe1100937. N Engl J Med. 2011. PMID: 21542748 No abstract available.
180 results